Medical News

RSS

Analyzing the court's possible impact

Consumers, small businesses and even the health insurance marketplace will face significant ramifications depending on how the court rules.

22 Jun 2012

Sanford Health CAO receives NOFAS Excellence Award for commitment to FAS

H. Eugene Hoyme, MD, chief academic officer for Sanford Health and president of Sanford , has received the 2012 Excellence Award from the National Organization on Fetal Alcohol Syndrome (NOFAS), joining the ranks of almost 40 past recipients that include Senator John McCain and the late Ted Kennedy.

22 Jun 2012

Shanghai Institutes of Preventative Medicine, Gentris sign MOU to advance personalized medicine

Gentris Corporation, a global leader in the application of genomic biomarkers to clinical studies, announced today that it has signed a Memorandum of Understanding with the Shanghai Institutes of Preventative Medicine to advance global personalized medicine.

22 Jun 2012

Janssen receives FDA complete response letter for XARELTO sNDA

Janssen Research & Development, LLC (Janssen R&D) announced today the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding a supplemental New Drug Application (sNDA) for XARELTO (rivaroxaban) for the reduction of the risk of secondary cardiovascular events in patients with acute coronary syndrome (ACS).

22 Jun 2012

IU gastroenterologist develops first guidelines for diagnosis and management of NAFLD

An Indiana University School of Medicine gastroenterologist led a team of distinguished physicians who developed the first guidelines for diagnosis and management of non-alcoholic fatty liver disease.

22 Jun 2012

U.N. agencies renew commitment to REACH initiative to combat child hunger, malnutrition

"United Nations agencies on Wednesday stressed the need to tackle child hunger and undernutrition in the pursuit of sustainable development, highlighting a joint initiative that offers practical and effective approaches to combat this problem in the most affected countries," the U.N. News Centre reports.

22 Jun 2012

Fructose may not be as bad for us as previously thought

A new study by researchers at St. Michael's Hospital suggests that fructose may not be as bad for us as previously thought and that it may even provide some benefit.

22 Jun 2012

Scientists identify cause of double-cortex syndrome

Researchers at McGill University have discovered the cause of an inherited form of epilepsy. The disease, known as double-cortex syndrome, primarily affects females and arises from mutations on a gene located on the X chromosome. Drs. Susanne Bechstedt and Gary Brouhard of the Department of Biology have used a highly advanced microscope to discover how these mutations cause a malformation of the human brain.

22 Jun 2012

Depomed acquires all rights to Zipsor from Xanodyne

Depomed, Inc. today announced that it has acquired all rights to Zipsor (diclofenac potassium) Liquid Filled Capsules from Xanodyne Pharmaceuticals, Inc. Zipsor is a non-steroidal anti-inflammatory drug (NSAID) indicated for relief of mild to moderate acute pain in adults.

22 Jun 2012

Southern Implants, Keystone announce merger agreement

Keystone Dental, Inc., a leading oral healthcare company dedicated to the delivery of breakthrough implant technology, and Southern Implants, Inc., a producer of unique and innovative dental implant technologies aimed to simplify clinical challenges for implant surgeons and restorative dentists, today announced the companies have merged.

From Danaher 22 Jun 2012

U.S. Department of Justice, Harden Healthcare reach settlement agreement

Harden Healthcare, a leading senior healthcare services provider and owner of Voyager HospiceCare and Hospice Care of Kansas, announced today that a settlement agreement has been reached with the U.S. Department of Justice.

22 Jun 2012

Link between Olmesartan drug and severe GI issues

Mayo Clinic researchers have discovered an association between a commonly prescribed blood pressure drug, Olmesartan, and severe gastrointestinal issues such as nausea, vomiting, diarrhea, weight loss and electrolyte abnormalities -- symptoms common among those who have celiac disease.

22 Jun 2012

MedData launches patient satisfaction assessment services for healthcare industry

MedData, Inc., a leading provider of revenue cycle management services, recently introduced comprehensive patient satisfaction assessment services for the healthcare industry.

22 Jun 2012

Moderate alcohol intake during pregnancy does not influence child's development and intelligence

Children born by mothers who have of consumed between 1 and 6 alcohol units per week are just as intelligent and well-developed as children of abstaining mothers. Mothers who have been drinking 5 or more drinks on a single occasion a limited number of times before realizing that they were pregnant may also breathe a sigh of relief; their children have not been harmed.

22 Jun 2012

Patients with MS appear to have reduced risk of cancer

Multiple sclerosis (MS) patients appear to have a lower cancer risk, according to a new study led by researchers at the University of British Columbia and Vancouver Coastal Health.

22 Jun 2012

The new wave of health care thinking: 'Frugal innovation'

The new wave of thinking effectively turns on its head the idea that healthcare innovation must always make something more high-tech, more sophisticated, more complex - and hence more expensive.

22 Jun 2012

Selenium reduces Staph populations in medical implants

Selenium is an inexpensive element that naturally belongs in the body. It is also known to combat bacteria. Still, it had not been tried as an antibiotic coating on a medical device material. In a new study, Brown University engineers report that when they used selenium nanoparticles to coat polycarbonate, the material of catheters and endotracheal tubes, the results were significant reductions in cultured populations of Staphylococcus aureus bacteria, sometimes by as much as 90 percent.

22 Jun 2012

New signal transduction pathway might be fruitful target for cancer drugs

Researchers at the University of California, San Diego School of Medicine have uncovered a new signal transduction pathway specifically devoted to the regulation of alternative RNA splicing, a process that allows a single gene to produce or code multiple types of protein variants. The discovery, published in the June 27, 2012 issue of Molecular Cell, suggests the new pathway might be a fruitful target for new cancer drugs.

22 Jun 2012

Study: Unexpected activity of estrogenic compounds during early stages of embryonic development

Chemicals in the environment that mimic estrogen can strongly influence the development of humans and other animals. New research to be presented at the 2012 International Zebrafish Development and Genetics Conference, held June 20-24 in Madison, Wisconsin, reveals that these substances may act even earlier than previously realized, at the very beginning stages of embryonic development.

22 Jun 2012

Aeterna Zentaris announces perifosine Phase 1 trial on neuroblastoma

Aeterna Zentaris Inc. today announced that Phase 1 trial results for its oral PI3K/Akt inhibitor, perifosine, showed the drug's activity against chemo-resistant and radio-resistant neuroblastoma, while allowing good quality of life and sparing vital organs. Neuroblastoma is a type of childhood cancer which usually begins in nerve tissues.

22 Jun 2012